Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Mar 15;101(6):1273–1282. doi: 10.1172/JCI1335

Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.

R P Xiao 1, E D Tomhave 1, D J Wang 1, X Ji 1, M O Boluyt 1, H Cheng 1, E G Lakatta 1, W J Koch 1
PMCID: PMC508681  PMID: 9502768

Abstract

While an age-associated diminution in myocardial contractile response to beta-adrenergic receptor (beta-AR) stimulation has been widely demonstrated to occur in the context of increased levels of plasma catecholamines, some critical mechanisms that govern beta-AR signaling must still be examined in aged hearts. Specifically, the contribution of beta-AR subtypes (beta1 versus beta2) to the overall reduction in contractile response with aging is unknown. Additionally, whether G protein-coupled receptor kinases (GRKs), which mediate receptor desensitization, or adenylyl cyclase inhibitory G proteins (Gi) are increased with aging has not been examined. Both these inhibitory mechanisms are upregulated in chronic heart failure, a condition also associated with diminished beta-AR responsiveness and increased circulatory catecholamines. In this study, the contractile responses to both beta1-AR and beta2-AR stimulation were examined in rat ventricular myocytes of a broad age range (2, 8, and 24 mo). A marked age-associated depression in contractile response to both beta-AR subtype stimulation was observed. This was associated with a nonselective reduction in the density of both beta-AR subtypes and a reduction in membrane adenylyl cyclase response to both beta-AR subtype agonists, NaF or forskolin. However, the age-associated diminutions in contractile responses to either beta1-AR or beta2-AR stimulation were not rescued by inhibiting Gi with pertussis toxin treatment. Further, the abundance or activity of beta-adrenergic receptor kinase, GRK5, or Gi did not significantly change with aging. Thus, we conclude that the positive inotropic effects of both beta1- and beta2-AR stimulation are markedly decreased with aging in rat ventricular myocytes and this is accompanied by decreases in both beta-AR subtype densities and a reduction in membrane adenylate cyclase activity. Neither GRKs nor Gi proteins appear to contribute to the age-associated reduction in cardiac beta-AR responsiveness.

Full Text

The Full Text of this article is available as a PDF (264.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrass I. B., Davis J. L., Scarpace P. J. Isoproterenol responsiveness and myocardial beta-adrenergic receptors in young and old rats. J Gerontol. 1982 Mar;37(2):156–160. doi: 10.1093/geronj/37.2.156. [DOI] [PubMed] [Google Scholar]
  2. Altschuld R. A., Starling R. C., Hamlin R. L., Billman G. E., Hensley J., Castillo L., Fertel R. H., Hohl C. M., Robitaille P. M., Jones L. R. Response of failing canine and human heart cells to beta 2-adrenergic stimulation. Circulation. 1995 Sep 15;92(6):1612–1618. doi: 10.1161/01.cir.92.6.1612. [DOI] [PubMed] [Google Scholar]
  3. Bristow M. R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986 Sep;59(3):297–309. doi: 10.1161/01.res.59.3.297. [DOI] [PubMed] [Google Scholar]
  4. Bristow M. R., Minobe W. A., Raynolds M. V., Port J. D., Rasmussen R., Ray P. E., Feldman A. M. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest. 1993 Dec;92(6):2737–2745. doi: 10.1172/JCI116891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brodde O. E. The functional importance of beta 1 and beta 2 adrenoceptors in the human heart. Am J Cardiol. 1988 Aug 11;62(5):24C–29C. doi: 10.1016/s0002-9149(88)80063-8. [DOI] [PubMed] [Google Scholar]
  6. Brown L., Deighton N. M., Bals S., Söhlmann W., Zerkowski H. R., Michel M. C., Brodde O. E. Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol. 1992 Feb;19(2):222–232. doi: 10.1097/00005344-199202000-00011. [DOI] [PubMed] [Google Scholar]
  7. Böhm M., Dorner H., Htun P., Lensche H., Platt D., Erdmann E. Effects of exercise on myocardial adenylate cyclase and Gi alpha expression in senescence. Am J Physiol. 1993 Mar;264(3 Pt 2):H805–H814. doi: 10.1152/ajpheart.1993.264.3.H805. [DOI] [PubMed] [Google Scholar]
  8. Cerbai E., Guerra L., Varani K., Barbieri M., Borea P. A., Mugelli A. Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study. Br J Pharmacol. 1995 Sep;116(2):1835–1842. doi: 10.1111/j.1476-5381.1995.tb16671.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cerbai E., Masini I., Mugelli A. Electrophysiological characterization of cardiac beta 2-adrenoceptors in sheep Purkinje fibers. J Mol Cell Cardiol. 1990 Aug;22(8):859–870. doi: 10.1016/0022-2828(90)90117-k. [DOI] [PubMed] [Google Scholar]
  10. Chin J. H., Hiremath A. N., Hoffman B. B. cAMP signaling mechanisms with aging in rats. Mech Ageing Dev. 1996 Jan 5;86(1):11–26. doi: 10.1016/0047-6374(95)01676-7. [DOI] [PubMed] [Google Scholar]
  11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  12. Dohlman H. G., Thorner J., Caron M. G., Lefkowitz R. J. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem. 1991;60:653–688. doi: 10.1146/annurev.bi.60.070191.003253. [DOI] [PubMed] [Google Scholar]
  13. Eschenhagen T., Mende U., Nose M., Schmitz W., Scholz H., Haverich A., Hirt S., Döring V., Kalmár P., Höppner W. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res. 1992 Apr;70(4):688–696. doi: 10.1161/01.res.70.4.688. [DOI] [PubMed] [Google Scholar]
  14. Feldman A. M. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation. 1993 May;87(5 Suppl):IV27–IV34. [PubMed] [Google Scholar]
  15. Fleg J. L., Tzankoff S. P., Lakatta E. G. Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males. J Appl Physiol (1985) 1985 Oct;59(4):1033–1039. doi: 10.1152/jappl.1985.59.4.1033. [DOI] [PubMed] [Google Scholar]
  16. Freedman N. J., Liggett S. B., Drachman D. E., Pei G., Caron M. G., Lefkowitz R. J. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem. 1995 Jul 28;270(30):17953–17961. doi: 10.1074/jbc.270.30.17953. [DOI] [PubMed] [Google Scholar]
  17. Gómez A. M., Valdivia H. H., Cheng H., Lederer M. R., Santana L. F., Cannell M. B., McCune S. A., Altschuld R. A., Lederer W. J. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997 May 2;276(5313):800–806. doi: 10.1126/science.276.5313.800. [DOI] [PubMed] [Google Scholar]
  18. Hausdorff W. P., Caron M. G., Lefkowitz R. J. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 1990 Aug;4(11):2881–2889. [PubMed] [Google Scholar]
  19. Inglese J., Freedman N. J., Koch W. J., Lefkowitz R. J. Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem. 1993 Nov 15;268(32):23735–23738. [PubMed] [Google Scholar]
  20. Kiuchi K., Shannon R. P., Komamura K., Cohen D. J., Bianchi C., Homcy C. J., Vatner S. F., Vatner D. E. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest. 1993 Mar;91(3):907–914. doi: 10.1172/JCI116312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koch W. J., Rockman H. A., Samama P., Hamilton R. A., Bond R. A., Milano C. A., Lefkowitz R. J. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. 1995 Jun 2;268(5215):1350–1353. doi: 10.1126/science.7761854. [DOI] [PubMed] [Google Scholar]
  22. Korzick D. H., Xiao R. P., Ziman B. D., Koch W. J., Lefkowitz R. J., Lakatta E. G. Transgenic manipulation of beta-adrenergic receptor kinase modifies cardiac myocyte contraction to norepinephrine. Am J Physiol. 1997 Jan;272(1 Pt 2):H590–H596. doi: 10.1152/ajpheart.1997.272.1.H590. [DOI] [PubMed] [Google Scholar]
  23. Kuznetsov V., Pak E., Robinson R. B., Steinberg S. F. Beta 2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res. 1995 Jan;76(1):40–52. doi: 10.1161/01.res.76.1.40. [DOI] [PubMed] [Google Scholar]
  24. Lakatta E. G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993 Apr;73(2):413–467. doi: 10.1152/physrev.1993.73.2.413. [DOI] [PubMed] [Google Scholar]
  25. Lakatta E. G., Gerstenblith G., Angell C. S., Shock N. W., Weisfeldt M. L. Diminished inotropic response of aged myocardium to catecholamines. Circ Res. 1975 Feb;36(2):262–269. doi: 10.1161/01.res.36.2.262. [DOI] [PubMed] [Google Scholar]
  26. Lohse M. J., Benovic J. L., Codina J., Caron M. G., Lefkowitz R. J. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 1990 Jun 22;248(4962):1547–1550. doi: 10.1126/science.2163110. [DOI] [PubMed] [Google Scholar]
  27. Motomura S., Reinhard-Zerkowski H., Daul A., Brodde O. E. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J. 1990 Mar;119(3 Pt 1):608–619. doi: 10.1016/s0002-8703(05)80284-4. [DOI] [PubMed] [Google Scholar]
  28. Narayanan N., Derby J. A. Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. Mech Ageing Dev. 1982 Jun;19(2):127–139. doi: 10.1016/0047-6374(82)90004-5. [DOI] [PubMed] [Google Scholar]
  29. Ng A. V., Callister R., Johnson D. G., Seals D. R. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension. 1993 Apr;21(4):498–503. doi: 10.1161/01.hyp.21.4.498. [DOI] [PubMed] [Google Scholar]
  30. Premont R. T., Koch W. J., Inglese J., Lefkowitz R. J. Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases. J Biol Chem. 1994 Mar 4;269(9):6832–6841. [PubMed] [Google Scholar]
  31. Rockman H. A., Choi D. J., Rahman N. U., Akhter S. A., Lefkowitz R. J., Koch W. J. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9954–9959. doi: 10.1073/pnas.93.18.9954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sakai M., Danziger R. S., Xiao R. P., Spurgeon H. A., Lakatta E. G. Contractile response of individual cardiac myocytes to norepinephrine declines with senescence. Am J Physiol. 1992 Jan;262(1 Pt 2):H184–H189. doi: 10.1152/ajpheart.1992.262.1.H184. [DOI] [PubMed] [Google Scholar]
  33. Scarpace P. J., Abrass I. B. Beta-adrenergic agonist-mediated desensitization in senescent rats. Mech Ageing Dev. 1986 Aug;35(3):255–264. doi: 10.1016/0047-6374(86)90128-4. [DOI] [PubMed] [Google Scholar]
  34. Scarpace P. J. Decreased receptor activation with age. Can it be explained by desensitization? J Am Geriatr Soc. 1988 Nov;36(11):1067–1071. doi: 10.1111/j.1532-5415.1988.tb04379.x. [DOI] [PubMed] [Google Scholar]
  35. Scarpace P. J. Forskolin activation of adenylate cyclase in rat myocardium with age: effects of guanine nucleotide analogs. Mech Ageing Dev. 1990 Mar 15;52(2-3):169–178. doi: 10.1016/0047-6374(90)90122-v. [DOI] [PubMed] [Google Scholar]
  36. Shu Y., Scarpace P. J. Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging. J Cardiovasc Pharmacol. 1994 Feb;23(2):188–193. [PubMed] [Google Scholar]
  37. Tumer N., Houck W. T., Roberts J. Upregulation of adrenergic beta receptor subtypes in the senescent rat heart. Mech Ageing Dev. 1989 Sep;49(3):235–243. doi: 10.1016/0047-6374(89)90074-2. [DOI] [PubMed] [Google Scholar]
  38. Ungerer M., Böhm M., Elce J. S., Erdmann E., Lohse M. J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993 Feb;87(2):454–463. doi: 10.1161/01.cir.87.2.454. [DOI] [PubMed] [Google Scholar]
  39. Ungerer M., Kessebohm K., Kronsbein K., Lohse M. J., Richardt G. Activation of beta-adrenergic receptor kinase during myocardial ischemia. Circ Res. 1996 Sep;79(3):455–460. doi: 10.1161/01.res.79.3.455. [DOI] [PubMed] [Google Scholar]
  40. White M., Roden R., Minobe W., Khan M. F., Larrabee P., Wollmering M., Port J. D., Anderson F., Campbell D., Feldman A. M. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation. 1994 Sep;90(3):1225–1238. doi: 10.1161/01.cir.90.3.1225. [DOI] [PubMed] [Google Scholar]
  41. Xiao R. P., Hohl C., Altschuld R., Jones L., Livingston B., Ziman B., Tantini B., Lakatta E. G. Beta 2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994 Jul 22;269(29):19151–19156. [PubMed] [Google Scholar]
  42. Xiao R. P., Ji X., Lakatta E. G. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995 Feb;47(2):322–329. [PubMed] [Google Scholar]
  43. Xiao R. P., Lakatta E. G. Beta 1-adrenoceptor stimulation and beta 2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells. Circ Res. 1993 Aug;73(2):286–300. doi: 10.1161/01.res.73.2.286. [DOI] [PubMed] [Google Scholar]
  44. Xiao R. P., Lakatta E. G. Deterioration of beta-adrenergic modulation of cardiovascular function with aging. Ann N Y Acad Sci. 1992 Dec 26;673:293–310. doi: 10.1111/j.1749-6632.1992.tb27465.x. [DOI] [PubMed] [Google Scholar]
  45. Xiao R. P., Spurgeon H. A., O'Connor F., Lakatta E. G. Age-associated changes in beta-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest. 1994 Nov;94(5):2051–2059. doi: 10.1172/JCI117559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zhou Y. Y., Cheng H., Bogdanov K. Y., Hohl C., Altschuld R., Lakatta E. G., Xiao R. P. Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol. 1997 Sep;273(3 Pt 2):H1611–H1618. doi: 10.1152/ajpheart.1997.273.3.H1611. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES